Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3COMET-HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv ...

KSI-501 is being developed for the treatment of high prevalence retinal vascular diseases to address the unmet needs of extended durability and targeting disease biology ... Kodiak Sciences®, ABCTM, ...

We are thrilled to announce that Recursion is setting a new gold standard for the industry with the release of ...

In the journal ACS Synthetic Biology, they now report that their bioengineered yeast ... This research was funded by the ...

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, including those involving the tumor suppressor protein p53, are widely studied ...

In 1975, Annie Dillard won the Pulitzer Prize for her book Pilgrim at Tinker Creek, a poetic chronicling of her creek-side ...

Google VP and Head of Research Yossi Matias said learning to code remains 'as important as ever' despite a changing tech ...

Researchers demonstrate AI-enhanced MRI's potential in diagnosing endometrial cancer, achieving superior accuracy and ...

The rhesus macaque monkeys that escaped a South Carolina medical lab this week are among the most studied animals on the ...

I was an average student with few ambitions to enter college. I got the push I needed from a fellow middle-schooler with a go ...